Indus Biotech Limited - life sciences in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U24231MH1995PLC085656 Incorporated 16 February 1995 ROC Pune HQ Pune, Maharashtra, India
Active Public Limited Company life sciences MSME · Medium
Revenue · FY 2025
₹71.42 Cr
▲ 2% YoY
Net profit · FY 2025
₹3.68 Cr
Net margin 5.2%
EBITDA · FY 2025
₹10.88 Cr
EBITDA margin 15.2%
Authorised capital
₹43 Cr
Registered with MCA
Paid-up capital
₹10.48 Cr
Issued & subscribed
Open charges
₹2.93 Cr
Satisfied ₹22.02 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
121
Provident fund records

About Indus Biotech Limited

Data last updated:

Indus Biotech Limited is a public limited company based in Pune, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 February 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231MH1995PLC085656. Its GSTIN is 27AAACI5708E1ZT (Maharashtra).

The company has an authorised share capital of ₹43 Cr and a paid-up capital of ₹10.48 Cr. It was formerly known as Indus Biotech Private Limited and Indus Natural Products Private Limited. It is led by directors including Sunil Dutt Bhaskaran (Managing Director) and Rajan Ramaswamy Srinivasan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Rahul Residency Plot Nos. 6 & 7 Off Salunke Vihar Road Kondhwa, Pune, Maharashtra, India – 411048.

As per the financials filed for FY 2025, the company reported a revenue of ₹71.42 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹3.68 Cr (net margin 5.2%) and EBITDA of ₹10.88 Cr (EBITDA margin 15.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.

The company has about 121 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Indus Biotech. As per MCA filings, the company has open charges of ₹2.93 Cr and satisfied charges of ₹22.02 Cr on record. Court records list 25 cases involving the company, including 15 filed by the company and 10 filed against it; 1 case is pending. The company has 18 deals on record (11 funding rounds, 6 secondary share transfers, 1 acquisition), with disclosed funding of ₹17.26 Cr; the latest was in June 2025. The company has 15 MSME Form 1 returns on record between 2020 and 2024, listing 1,834 overdue payments to 183 micro and small suppliers.

Indus Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0017172). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indusbiotech.com.

Company details

CIN U24231MH1995PLC085656
Registration Number 085656
Incorporation Date 16 February 1995
ROC Pune
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-26-0017172

Name history

Indus Biotech has undergone 2 name changes throughout its history. The company was previously known as Indus Biotech Private Limited, and Indus Natural Products Private Limited. The current legal name is Indus Biotech Limited.

Company NameStatus
Indus Biotech LimitedCurrent
Indus Biotech Private LimitedPrevious
Indus Natural Products Private LimitedPrevious

CIN history

Indus Biotech has one previous CIN (Corporate Identification Number): U24231MH1995PTC085656. The current CIN is U24231MH1995PLC085656, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231MH1995PLC085656Current
U24231MH1995PTC085656Previous

Recognitions & Rankings of Indus Biotech

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-26-0017172

Contact details

Indus Biotech Limited's registered office is in Pune, Maharashtra. Its website is indusbiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    1 Rahul Residency Plot Nos. 6 & 7 Off Salunke Vihar Road Kondhwa, Pune, Maharashtra, India – 411048
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Indus Biotech Limited, buy the company report.

Comprehensive company report
Indus Biotech Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Indus Biotech operates one associated brand: Indus Biotech. Each brand links to its own profile.

BrandDescriptionWebsite
Drugs for autoimmune, CNS, infectious, and lifestyle diseases are developed.indusbiotech.com

Business activity

The main business activity of Indus Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Indus Biotech Limited, buy the company report.

Financials of Indus Biotech Limited

FY 2025 filings available

Indus Biotech Limited reported revenue of ₹71.42 Cr (up 2% YoY) for FY 2025.

Revenue · FY 2025
₹71.42 Cr ▲ 2%
Net profit · FY 2025
₹3.68 Cr margin 5.2%
EBITDA · FY 2025
₹10.88 Cr margin 15.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▼ 10%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 37%
5 years · compounded
▼ 28%

Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.88 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.68 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.2%
Net Profit Margin5.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Indus Biotech Limited, buy the company report.

Board of directors and KMP of Indus Biotech Limited

Indus Biotech Limited currently reports 6 directors and 1 key managerial person. 8 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Rajan Ramaswamy SrinivasanDirector01 Jan 200125 Years 10 MonthsCurrent
Achyut Jayatirthrao HuilgolCfo14 Mar 20188 Years 8 MonthsCurrent
Ranjeet Palliyil SrinivasanDirector16 Feb 199531 Years 9 MonthsCurrent
Shrikant Jayawant PatilDirector15 Nov 20215 Years 0 MonthsCurrent
Anil Pratap KumarDirector15 Nov 20215 Years 0 MonthsCurrent
Pankaj MehraDirector26 Sep 20251 Years 1 MonthsCurrent
Showing 6 of 7 current directors and KMP. View all directors and KMP

Auditor

Indus Biotech Limited is audited by MSKA & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MSKA & AssociatesFY 2023105047W

Shareholding

The shareholding of Indus Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Indus Biotech Limited, buy the company report.

Charges & borrowings

Open charges
₹2.93 Cr
Satisfied charges
₹22.02 Cr
Breakdown by lending institutions
Others₹2.00 Cr
Vijaya Bank₹0.93 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Jun 2021100459522Others₹2 CrOpen
15 Jun 2017100147555Vijaya Bank₹92.68 LakhOpen
27 Oct 201510602344Others₹13.48 CrSatisfied
15 Oct 201110316247Vijaya Bank₹52 LakhSatisfied
25 Aug 200910175309Vijaya Bank₹4 CrSatisfied

To see the full charge records of Indus Biotech Limited, buy the company report.

Total charge records: 10 View all charges

Deals & funding

Indus Biotech Limited has 18 deals on record (11 funding rounds, 6 secondary share transfers, 1 acquisition), with disclosed funding of ₹17.26 Cr; the latest was in June 2025.

Total deals
18
Funding rounds
11
Secondary share transfers
6
Acquisition
1
Disclosed funding
₹17.26 Cr

Deals on record (5 of 18)

WhenDealAmountParties
Sep 2021Secondary share transferUndisclosedSeller: Kotak Private Equity
Oct 2012Secondary share transferUndisclosedBuyer: Kotak Securities Limited
Seller: Kotak Mahindra Investments Limited
Mar 2009Secondary share transferUndisclosedBuyer: Kotak Private Equity
Seller: Kotak Mahindra Investments Limited
Sep 2008Funding round₹5.55 CrInvestors: Kotak Private Equity
Sep 2008Funding round₹12.5 LakhInvestors: Kotak Private Equity

To see the full deal history of Indus Biotech Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Indus Biotech Limited has 15 MSME Form 1 returns on record between 2020 and 2024, listing 1,834 overdue payments to 183 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 183)

SupplierAmount dueDue sinceReported on
an individual supplier
Universal Calibration Services Private Limited
B.B.Chemicals Private Limited
Anatek Services Private Limited
GK Travels and Services

To see the full MSME payment records of Indus Biotech Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Indus Biotech has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Trigonella Labs Private LimitedU74999PN2017PTC172331

To see the full group structure of Indus Biotech Limited, buy the company report.

Employees & EPFO

Indus Biotech Limited has a workforce of 121 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
121
Active EPFO establishments
1
Employee growth
-3.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27121
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Indus Biotech Limited, buy the company report.

GST

Indus Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACI5708E1ZTMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Indus Biotech Limited, buy the company report.

Recent activity

Indus Biotech Limited has 15 board changes on record since 1995: 7 appointments and 8 cessations. The latest: Pankaj Mehra ceased to be Additional Director on 29 Sep 2025.

AGM
Indus Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Pankaj Mehra ceased to be Additional Director.
Appointed
Pankaj Mehra was appointed as Director.
Ceased
Himanshu Nivsarkar ceased to be Nominee Director.
Filing
Indus Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Others of Rs. 2.00 Cr registered on 23 Jun 2021 with Charge ID 100459522 was modified on 29 Mar 2025.
Ceased
Jaiprakash Prabhakaran Mudakkanaveetil ceased to be Director.
Ceased
Rajeshree Rajnikant Sabnavis ceased to be Director.
Appointed
Anil Pratap Kumar was appointed as Director.
Appointed
Shrikant Jayawant Patil was appointed as Director.
Ceased
Nitin Jagannath Deshmukh ceased to be Director.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100459522 was registered on 23 Jun 2021.

28 earlier events are in the company report.

Frequently asked questions

Indus Biotech is an active public limited company based in Pune, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 February 1995 (31+ years old) and is registered under CIN U24231MH1995PLC085656.

Indus Biotech has 7 current directors and KMP:

The latest financial statements of Indus Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Indus Biotech is 27AAACI5708E1ZT, registered in Maharashtra.

The CIN (Corporate Identification Number) of Indus Biotech is U24231MH1995PLC085656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Indus Biotech has 25 court cases on record: 15 filed by the company and 10 filed against it. 1 is pending. Most are in the high courts.

Indus Biotech was incorporated on 16 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Pune.

Indus Biotech has 18 deals on record (11 funding rounds, 6 secondary share transfers, 1 acquisition), with disclosed funding of ₹17.26 Cr; the latest was in June 2025.

Pankaj Mehra ceased to be Additional Director on 29 Sep 2025. Pankaj Mehra was appointed as Director on 26 Sep 2025. Himanshu Nivsarkar ceased to be Nominee Director on 30 Jun 2025. Indus Biotech has 15 board changes on record in total.

Yes, Indus Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-26-0017172).

Indus Biotech has 15 MSME Form 1 returns on record between 2020 and 2024, listing 1,834 overdue payments to 183 micro and small suppliers. The latest return was filed on 29 Apr 2024.